Keywords
consitutive androstane receptor,chimeric antigen receptor,nuclear receptor subfamily 1 group I member 3,chimeric antigen,CAR,CAR T,car protein,car,receptor,receptor protein,chimeric,immunoreceptor,chimeric t cell receptor,artificial t cell receptor,engineered t cell,scFV,vh,vl,antigen target,antigen recognition,antigen-binding,t-cell activation,cancer treatment,cancer therapy,tumor attack,antitumor,cytotoxic,living drug,car gene,genetic engineering,immunology,transduction,antigen recognition domain,hinge region,transmembrane domain,intracellular T cell signaling domain,costimulatory domain,CD3,CD3z,CD3γ,nuclear receptor subfamily 1,T cell,Tcell,T-cell,editable,chimeric antigen,CAR,CART,CAR-T,CAR1,NR1I3,MB67,car-t,cart,car t,car,car protein